"10.1371_journal.pone.0138069","plos one","2015-10-13T00:00:00Z","Micaela B Reddy; Kuo-Hsiung Yang; Gauri Rao; Craig R Rayner; Jing Nie; Chandrasena Pamulapati; Bindumadhav M Marathe; Alan Forrest; Elena A Govorkova","Department of Drug Metabolism and Pharmacokinetics, Hoffmann-La Roche Inc., Nutley, New Jersey, United States of America; Department of Pharmacy Practice, University of Buffalo, Buffalo, New York, United States of America; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America","Conceived and designed the experiments: MBR CRR AF EAG. Performed the experiments: K-HY GR JN CP BMM. Analyzed the data: MBR K-HY GR JN CP BMM EAG. Contributed reagents/materials/analysis tools: CRR EAG. Wrote the paper: MBR K-HY GR CRR JN CP BMM AF EAG.","The authors have the following interests. At the time this work was conducted, M.B. Reddy, K.-H. Yang, C.R. Rayner, J. Nie, and C. Pamulapati were employees of Hoffmann-La Roche. G. Rao and K.-H. Yang held positions funded by Hoffmann-La Roche while at the University of Buffalo. This work was funded by Hoffmann-La Roche Inc. (Nutley, NJ, USA) and support for third-party writing assistance for this manuscript was provided by F. Hoffmann-La Roche Ltd. Hoffmann-La Roche produces oseltamivir under the trade name Tamiflu. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","10","Micaela B Reddy","MBR",9,TRUE,4,5,7,9,TRUE,TRUE,FALSE,0,NA,FALSE
